About this course

Learning Objectives

• Define the impact frequent Cannabis use has on Anxiety, Depression, and Inattention based on medical studies
• Learn how to confidently discuss with students the impact of THC on the brain and body.
• Identify the botany of the Cannabis plant and how THC is extracted and used.

Learning Levels

• This animated webinar is for mental health professionals. Knowledge of Cannabis/THC is not required.

Course Instructor(s)

• 

  Matthew Lally M.D.

  Addiction Medicine Specialist. College Health Psychiatrist, Harvard Psychiatry Instructor

  Dr. Lally is board-certified in Psychiatry and board-certified in Addiction Medicine. He has years of experience as a College Mental Health Psychiatrist and teaches student mental health to psychiatry residents from Harvard Medical School programs . He is the creator of the #1 Animated Mental Health App on the Apple App Store: "Everybody's Guide to Psych Meds." He is a member of the American College Health Association.

Disclosure

References

• Marijuana, N. I. D. A. (2022). hallucinogen use among young adults reached all time-high in 2021. National Institute on Drug Abuse website.
• Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., & Lynskey, M. T. (2021). Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis. Addiction, 116(5), 1000-1010.
• Mezey, L., & Winkler, A. (2021). Cannabis Legalization and College Mental Health. Current Psychiatry Reports, 23(4).
• Figueiredo, P. R., Tolomeo, S., Steele, J. D., & Baldacchino, A. (2020). Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 108, 358-369.
• MHSA Prevention Day, February 4, 2019 Elinore F. McCance-Katz, MD, PhD, Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
• McCance-Katz, E. F. (2019). Urgent and emerging issues in prevention: Marijuana, kratom, E-cigarettes. SAMHSA Prevention Day.
• Silver, R. J. (2019). The endocannabinoid system of animals. Animals, 9(9), 686.
• Bahorik, A. L., Leibowitz, A., Sterling, S. A., Travis, A., Weisner, C., & Satre, D. D. (2017). Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. Journal of affective disorders, 213, 168-171.
• Bossong, M. G., Mehta, M. A., van Berckel, B. N., Howes, O. D., Kahn, R. S., & Stokes, P. R. (2015). Further human evidence for striatal dopamine release induced by administration of∆ 9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology, 232, 2723-2729.
• Fuss, J., Steinle, J., Bindila, L., Auer, M. K., Kirchherr, H., Lutz, B., & Gass, P. (2015). A runner’s high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences, 112(42), 13105-13108.
• Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015). Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder. The Journal of clinical psychiatry, 76(9), 11266.
• Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., ... & Mattick, R. P. (2014). Young adult sequelae of adolescent cannabis use: an integrative analysis. The Lancet Psychiatry, 1(4), 286-293.
• McKenna, G. J. (2014). The current status of medical marijuana in the United States. Hawai'i Journal of Medicine & Public Health, 73(4), 105.
• Ries, R. K., Fiellin, D. A., Miller, S. C., & Saitz, R. (2014). The ASAM principles of addiction medicine. Lippincott Williams & Wilkins.
• Fitzgerald, K. T., Bronstein, A. C., & Newquist, K. L. (2013). Marijuana poisoning. Topics in companion animal medicine, 28(1), 8-12.
• Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual review of psychology, 64, 21-47.
• Hirvonen, J., Goodwin, R. S., Li, C. T., Terry, G. E., Zoghbi, S. S., Morse, C., ... & Innis, R. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular psychiatry, 17(6), 642-649.
• Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of addiction medicine, 5(1), 1-8.
• Justinová, Z., Yasar, S., Redhi, G. H., & Goldberg, S. R. (2011). The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. Journal of Neuroscience, 31(19), 7043-7048.
• Hayatbakhsh, M. R., Najman, J. M., Jamrozik, K., Mamun, A. A., Alati, R., & Bor, W. (2007). Cannabis and anxiety and depression in young adults: a large prospective study. Journal of the American Academy of Child & Adolescent Psychiatry, 46(3), 408-417.
• Booth, M. (2005). Cannabis: a history. Macmillan.
• Gignac, M., Wilens, T. E., Biederman, J., Kwon, A., Mick, E., & Swezey, A. (2005). Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you?. Journal of Child & Adolescent Psychopharmacology, 15(5), 742-750.
• Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., ... & Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418(6897), 530-534.
• Fried, P., Watkinson, B., James, D., & Gray, R. (2002). Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. Cmaj, 166(7), 887-891.
• Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002). Cannabis use and mental health in young people: cohort study. Bmj, 325(7374), 1195-1198.
• Gardner, E. L. (2000). What we have learned about addiction from animal models of drug self-administration. American Journal on Addictions, 9(4), 285-313.